A federal judge has posed some pointed questions for a hearing Wednesday where he will consider whether to grant preliminary approval to a Bayer-proposed settlement for a so-called “futures class” of plaintiffs who contract non-Hodgkin lymphoma.
To view this article, please
login. If you are not a current subscriber, you may sign up for a trial or view other subscription options
here.
![Steve headshot 250x200[1]](http://www.agri-pulse.com/ext/resources/Headshots/Staff-Photos/thumb/Steve_Headshot_250x200[1].JPG?1738947158)